N/A
N=4,658
International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)
Atrial Fibrillation
Bottom Line
View on ClinicalTrials.gov: NCT01119716 ↗Enrolled (actual)
4,658
Serious AEs
—
Results posted
Jan 2014
Primary outcome: Primary: Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission) — 1.3; 1.6; 1.4; 2.3 Percentage of Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Merck Sharp & Dohme LLC
- Primary completion
- Feb 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission) |
1.3; 1.6; 1.4; 2.3; 3.5; 2.8 | — |
| PRIMARY Co-Morbidity in Participants Presenting With Atrial Fibrillation at Baseline (Admission) |
7.8; 7.1; 7.5; 6.3; 5.1; 5.8 | — |
| PRIMARY Clinical Type of Atrial Fibrillation at Baseline (Admission) |
29.2; 33.6; 30.8; 27.2; 31.9; 28.9 | — |
| PRIMARY Treatments Utilized for Participants for Atrial Fibrillation |
1677; 792; 2469; 705; 609; 1314 | — |
| PRIMARY Percentage of Participants Who Had a Successful Electrical or Pharmacological Cardioversion |
69.5; 55.1; 64.2; 30.5; 44.9; 35.8 | — |
| PRIMARY Complications Experienced by Participants Who Underwent a Cardioversion for Treatment of Atrial Fibrillation |
2; 2; 4; 7; 3; 10 | — |
Summary
This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.
Eligibility Criteria
Inclusion Criteria
- Participant with documented atrial fibrillation (confirmed by electrocardiogram) in the hospital setting at the time of enrollment
- Planned cardioversion (of atrial fibrillation)
Exclusion Criteria
- Already enrolled in this or any other clinical trial
- Atrial flutter
Data sourced from ClinicalTrials.gov (NCT01119716). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.